Literature DB >> 28384968

Paraneoplastic Hypoglycaemia: A Rare Manifestation of Pelvic Gastrointestinal Stromal Tumour.

Ashish Singhal1, Rahat Hadi2, Kiranpreet Mehrotra3, Shivani Rastogi4, Shakeel Masood5.   

Abstract

Non-Islet Cell Tumour Induced Hypoglycaemia (NICTH), presenting with recurrent fasting hypoglycaemia is a very rare paraneoplastic syndrome. It usually presents with large metastatic mesenchymal tumours. NICTH secondary to Gastrointestinal Stromal Tumour (GIST) is even rarer. Diagnosis of NICTH is based on the low serum insulin level, low serum concentrations of Insulin Like Growth Factor (IGF-I) and IGF binding protein- III (IGFBP-III) in combination with elevated concentrations of pro-IGF-II. Various Immunohistochemical (IHC) markers are integral to diagnosis of GIST namely 2-deoxyglucose-6-phosphate phosphatase -1(DOG-1), Cluster Differentiation 34 (CD 34), Cluster Differentiation 117 (CD117). The management requires prompt intravenous hydration and glucose infusions followed by surgical resection. We hereby, report a rare case of a 65-year-old female with intractable fasting hypoglycaemia due to overproduction of "big" insulin-like growth factor II diagnosed to have pelvic GIST and managed by Steroids and Imatinib.

Entities:  

Keywords:  Mesenchymal tumour; Non-islet cell; Paraneoplastic syndrome

Year:  2017        PMID: 28384968      PMCID: PMC5376886          DOI: 10.7860/JCDR/2017/17146.9306

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  5 in total

1.  Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases.

Authors:  Daniel Pink; Dagmar Schoeler; Tanja Lindner; Peter C Thuss-Patience; Albrecht Kretzschmar; Heike Knipp; Udo Vanhoefer; Peter Reichardt
Journal:  J Clin Oncol       Date:  2005-09-20       Impact factor: 44.544

Review 2.  Paraneoplastic syndromes: an approach to diagnosis and treatment.

Authors:  Lorraine C Pelosof; David E Gerber
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

3.  c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.

Authors:  Eva Wardelmann; Iris Neidt; Erhard Bierhoff; Nicola Speidel; Christoph Manegold; Hans-Peter Fischer; Ulrich Pfeifer; Torsten Pietsch
Journal:  Mod Pathol       Date:  2002-02       Impact factor: 7.842

4.  Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia.

Authors:  W H Daughaday; M A Emanuele; M H Brooks; A L Barbato; M Kapadia; P Rotwein
Journal:  N Engl J Med       Date:  1988-12-01       Impact factor: 91.245

5.  Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report.

Authors:  Guillermo A Escobar; William A Robinson; Trevor L Nydam; Drew C Heiple; Glen J Weiss; Linda Buckley; Rene Gonzalez; Martin D McCarter
Journal:  BMC Cancer       Date:  2007-01-17       Impact factor: 4.430

  5 in total
  3 in total

1.  Novel case of a scleroderma-mimicking syndrome associated with gastrointestinal stromal tumour.

Authors:  Zaran Ahmad Butt; Wan Lin Ng; Kamal Osman; Donough Howard
Journal:  BMJ Case Rep       Date:  2021-03-04

2.  Effect of Gastrointestinal Bleeding on Gastrointestinal Stromal Tumor Patients: A Retrospective Cohort Study.

Authors:  Yuqian Huang; Rui Zhao; Yaping Cui; Yong Wang; Lin Xia; Yi Chen; Yong Zhou; Xiaoting Wu
Journal:  Med Sci Monit       Date:  2018-01-18

Review 3.  Pathophysiology and aetiology of hypoglycaemic crises.

Authors:  R K Morgan; Y Cortes; L Murphy
Journal:  J Small Anim Pract       Date:  2018-08-13       Impact factor: 1.522

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.